Latest in News & Research
Twelve-Week Treatment Regimen Reduces Facial Redness
Skin seemed less inflamed, improvement seen in overall skin appearance, and skin looked and felt healthier
By Physician’s Briefing Staff | | July 01, 2022
What Factors Are Associated With the Burden of Atopic Dermatitis?
Atopic dermatitis severity and time spent managing symptoms have the strongest associations with disease burden
By Dermsquared Editorial Team | | June 29, 2022
Is Mohs Micrographic Surgery Beneficial for High-Risk cSCC?
Mohs yields high five-year disease specific survival, local recurrence-free survival, and regional/distant metastasis-free survival
By Dermsquared Editorial Team | | June 29, 2022
Experts Address Lab Monitoring of Isotretinoin for Treating Acne
Consensus reached on recommendations to test alanine aminotransferase, triglycerides within a month prior to initiation and at peak dose
By Physician’s Briefing Staff | | June 29, 2022
Should Secukinumab Dosing for Psoriasis Be Adjusted for Patient Weight?
PASI 90 responses significantly higher for secukinumab 300 mg every two weeks versus every four weeks for patients weighing ≥90 kg
By Dermsquared Editorial Team | | June 22, 2022
Two Patient-Reported Outcome Measures Useful for Determining QoL With Acne
Systematic review finds that Acne-Q and CompAQ can be used for measuring acne-associated quality of life
By Dermsquared Editorial Team | | June 22, 2022
Prevalence of Metabolic Syndrome 32 Percent in Psoriasis Patients
Patients with psoriasis vulgaris or severe psoriasis had higher prevalence of MetS compared with other types
By Physician’s Briefing Staff | | June 22, 2022
Tiny Mites Are Feeding on Your Skin, But for How Long?
Survey shows lack of knowledge may lead to behaviors that contribute to sun damage, skin cancer
By Dennis Thompson (HealthDay News) | | June 22, 2022
Predictors of Diagnostic Delay in Psoriasis Identified
Male patients have longer diagnostic delay than female patients; longer diagnostic delay seen for those with psoriasis in specific areas
By Physician’s Briefing Staff | | June 21, 2022
Study Compares Baricitinib to Dexamethasone for COVID-19
Baricitinib plus remdesivir shows similar efficacy but better safety profile than dexamethasone plus remdesivir in hospitalized adults
By Physician’s Briefing Staff | | June 21, 2022
Skin Tags? Moles? Products Promising to Treat Them Can Do Real Harm
By Cara Murez (HealthDay News) | | June 20, 2022
Diffuse Reflectance Spectroscopy Can Help Assess Psoriasis Severity
Mexameter erythema readings are a good representation of skin oxygenated hemoglobin, but not deoxygenated hemoglobin
By Physician's Briefing Staff | | June 16, 2022
Immediate, Delayed Reactions to Fragrances ID'd in Thai Population
Cinnamic aldehyde and cinnamic alcohol were most frequently encountered substances in immediate, delayed reactions
By Dermsquared Editorial Team | | June 15, 2022
Lichen Sclerosus Linked to Depression, Anxiety in Adult Women
Lichen sclerosus remained significantly associated with depression and anxiety in multivariable analyses
By Dermsquared Editorial Team | | June 15, 2022
Global Seroprevalence of Tickborne Lyme Disease About 14.5 Percent
Factors associated with Bb seropositivity include male sex, age ≥50 years, residence in rural areas, suffering tick bites
By Physician's Briefing Staff | | June 14, 2022
FDA Approves First Pill to Treat Severe Alopecia Areata
Olumiant is the first FDA-approved alopecia therapy that treats the entire body rather than a specific spot
By Physician’s Briefing Staff | | June 14, 2022
Higher Fish Intake May Increase Melanoma Risk
Higher total fish intake, tuna intake, nonfried fish intake positively linked to risks of malignant melanoma, melanoma in situ
By Physician's Briefing Staff | | June 10, 2022
Tretinoin Precursors, Tretinoin Work Similarly for Facial Photodamage
MMP2 mRNA was significantly reduced in TTP-treated samples; changes in MMP2 were associated with changes in fine wrinkles
By Dermsquared Editorial Team | | June 08, 2022
Alopecia Areata Symptom Impact Scale Tied to Disease Severity, Response
Alopecia Areata Quality of Life Index showed no correlation with AA severity pretreatment or posttreatment
By Dermsquared Editorial Team | | June 08, 2022
Lotion, Cream, Gel, and Ointment Similarly Effective for Childhood Eczema
Patient choice and personal preferences should guide selection decisions
By Physician's Briefing Staff | | June 02, 2022
Do Personal Care Products Contribute to Frontal Fibrosing Alopecia?
Link seen for sunscreen and facial moisturizer; no link seen for facial cleanser, hair products, cosmetic foundation
By Dermsquared Editorial Team | | June 01, 2022
Can Reflectance Confocal Microscopy Reduce Unnecessary Excisions?
Adjunctive RCM associated with higher positive predictive value, lower benign-to-malignant ratio compared with standard therapeutic care alone
By Dermsquared Editorial Team | | June 01, 2022
Psoriasis Tied to Higher Risk for Nonalcoholic Fatty Liver Disease
Authors say this association may be relevant to psoriasis management with some antipsoriatic agents
By Physician’s Briefing Staff | | June 01, 2022
24 of 1200
Headline from the Week of February 09 - 15, 2026
Second Annual National Cancer Database Report Presented for 2022
By Elana Gotkine (HealthDay News) | | February 11, 2026
Presurgical Pembrolizumab Beneficial for Desmoplastic Melanoma
By Elana Gotkine (HealthDay News) | | February 11, 2026